Black Rock Inc. Yumanity Therapeutics, Inc. Transaction History

Black Rock Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.02 - $1.99 $24,866 - $48,514	-24,379 Reduced 36.08%	43,185 $79,000
Q1 2022 May 12, 2022	SELL	$0.97 - $3.27 $2,877 - $9,698	-2,966 Reduced 4.21%	67,564 $102,000
Q4 2021 Feb 10, 2022	BUY	$2.81 - $10.48 $1,756 - $6,550	625 Added 0.89%	70,530 $209,000
Q3 2021 Nov 09, 2021	BUY	$8.3 - $12.04 $37,316 - $54,131	4,496 Added 6.87%	69,905 $721,000
Q2 2021 Aug 11, 2021	BUY	$11.27 - $19.64 $737,159 - $1.28 Million	65,409 New	65,409 $762,000

Ticker YMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,856,500
Description
Yumanity Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of treatments for neurodegenerative diseases caused by protein misfolding. The company focuses on discovering disease-modifying therapies to treat neurodegenerative diseases, including Parkinson's disease, dementia with Lewy bodies, mu...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.